From Send2Press® Newswire — Print Friendly Version
Advertising and Marketing News
P R E S S R E L E A S E :
Eularis Updates Reports That Help Pharmaceutical Companies
Do More for Real Growth Than Simply Downsizing
Mon, 05 Apr 2010, 13:58:19 EDT
LONDON, U.K. (SEND2PRESS NEWSWIRE) -- The pharmaceutical industry is facing
unprecedented challenges on many fronts - a slew of patient expiries, a lack of
blockbusters in the pipeline to replace the patent expiries, decreasing growth in many
major markets, generic competition, constantly changing regulatory and competitive
environment rendering old tools for analysis obsolete, increased pressure on CEOs to
deliver shareholder growth resulting in budget cuts, downsizing, and less than optimal
results.
Therefore, given these challenges, today is the worst time in the history of
pharmaceuticals to be a pharmaceutical marketer.
Eularis has updated its reports that focus on specific key issues for pharma marketers
that help them understand how to handle these specific situations. These reports uncover practices to predict how and where
pharmaceutical marketing and sales investments will yield the highest market share and market share price and highlight real
life case studies.
Readers will benefit from the step-by-step guidelines on successfully implementing approaches for real and measurable
results available only in these reports.
Details about these updated reports can be found at:
www.ePharmaROI.com : How to Harness the Power of Social Media in Pharmaceutical eMarketing.
www.pharmaprelaunchroi.com : Pre-Launch Planning: Priming your Pharmaceutical Brand for Profit and Success.
www.GenericsDefenseStrategies.com : How to Plan an Effective Generics Defense Strategy: Planning, Tactics and
Implementation.
www.PatientAdherenceROI.com : Ensuring Profitable Patient Adherence Programs: Using Analytics and Metrics to Improve
the Bottom Line
www.PharmaIndustrySFE.com : Pharmaceutical Sales Force Effectiveness Metr